“Antibiotics 2026—Advances in Antimicrobial Action and Resistance” Conference was organized by MDPI from the 11th to the 14th of May 2026 in Barcelona, Spain. The conference allowed researchers and industry professionals from all around the world to exchange ideas and also update about their latest researches in the field on antimicrobial resistance and novel antimicrobials or therapeutics.
DC 09 Umama Qasim delivered an oral presentation on her project “A novel cyclic peptide CAP-18 and its enantiomer cyclic D-CAP-18 as potential agents against multidrug-resistant bacteria”.
The talk focused on the latest updates of the project being part of the BREAKthrough consortium. It was a great opportunity for the DC 09 to be able to share her work with the experts in the field using this forum.
